Cargando…
MET 14外显子跳跃突变NSCLC靶向治疗专家共识
The mesenchymal-epithelial transition factor (MET) exon 14 skipping mutation is mainly caused by the loss of c-Cbl tyrosine binding site. This mutation could result in a decrease in the degradation rate of proteasome-mediated MET proteins, trigger continuous activation of downstream pathways, and ul...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365964/ https://www.ncbi.nlm.nih.gov/pubmed/37488079 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.19 |
Ejemplares similares
-
EGFR 20外显子插入突变非小细胞肺癌规范化诊疗中国专家共识(2023版)
Publicado: (2023) -
MET 14外显子跳跃突变在非小细胞肺癌中的研究进展
Publicado: (2018) -
非小细胞肺癌EGFR外显子20插入突变检测和靶向药物研究进展
por: WANG, Yulu, et al.
Publicado: (2023) -
EGFR外显子20插入突变型NSCLC治疗的研究进展
por: XU, Meiyi, et al.
Publicado: (2023) -
老年肺癌外科治疗中国专家共识(2022版)
por: Lung Cancer Specialty Committee of Chinese Elderly Health Care Association, Enhanced Recovery after Surgery Specialty Committee of Tianjin Medical and Health Association,
Publicado: (2023)